PT  - JOURNAL ARTICLE
AU  - Eugene L Scharf
AU  - Patricia Kolbe
AU  - Su-Yeon Hwang
AU  - Natasha Thompson
AU  - Mara Gilbert
AU  - Faye Alexandrakis
AU  - Matthieu Bonjour
AU  - Evelyn Zeiler
AU  - Toshia Myers
TI  - A Pilot Study on the Effects of Medically Supervised, Water-Only Fasting and Refeeding on Cardiometabolic Risk
AID  - 10.1101/2020.08.07.20169680
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.08.07.20169680
4099  - http://medrxiv.org/content/early/2020/08/12/2020.08.07.20169680.short
4100  - http://medrxiv.org/content/early/2020/08/12/2020.08.07.20169680.full
AB  - The Fasting for Brain and Heart Health Study was a prospective, single-center, observational study examining the effects of medically supervised, water-only fasting followed by an exclusively whole-plant-food refeeding diet on accepted measures of cardiovascular risk and metabolic health. The study enrolled 48 overweight/obese, non-diabetic participants of which 26 completed the full study protocol. The participants fasted according to an established protocol at an independent medical center that reported mean fast and refeed lengths of 17 and 7 days, respectively. The primary endpoint was to describe mean glucose tolerance as indicated by Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) scores at baseline, end-of-fast (EOF), and end-of-refeed (EOR) visits. Secondary endpoints were to describe the effects of fasting and refeeding on accepted markers of cardiovascular risk. Here we show that medically supervised, water-only fasting and/or whole-plant-food refeeding reduced resting systolic blood pressure (SBP), abdominal circumference, low-density lipoprotein (LDL), and high-sensitivity C-reactive protein (hsCRP) after refeeding. An increase in HOMA-IR scores at EOR was also observed.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNot an applicable clinical trial.Funding StatementNo external funding was received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Institutional Review Board at the TrueNorth Health Foundation (TNHF2018-1).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study will be available upon request after peer-reviewed publication.